Health Care Equipment & Services

Chemed Corp’s CFO’s recent PSU trades and buybacks signal confidence in growth, blending liquidity needs with long‑term commitment to shareholders.

Chemed’s CEO buys shares amid a $300 M share‑repurchase and $0.60 dividend, signaling confidence in undervalued stock and a potential entry point for value investors.

Chemed insider buy signals confidence: VP’s 351-share purchase supports buy‑back and dividend plans, boosting investor sentiment amid solid earnings outlook.

Outset Medical insider selling spikes: 1.9 M shares off the books after earnings, 24% drop, 38% monthly loss—what it signals for investors and the company’s valuation.

CEO Bernard J’s large buy of 25,350 Edwards Lifesciences shares shows bullish insider confidence, potentially boosting the stock past its 52‑week low.

ORBC CFO Taylor Lawrence’s 181k‑RSU grant signals strong board confidence and may boost value after the planned Vivasure deal.

CEO Daniel Perez’s systematic purchase of 166,665 Hinge Health shares signals insider confidence, supporting the firm’s Q4 earnings boost and 2026 revenue outlook.

Insider buying at QuidelOrtho signals confidence amid a steep decline. Discover what the CEO, CFO, and executives’ recent purchases mean for investors.

McKesson insider sale: EVP Lau Michele sells 303 shares under 10b5‑1, hinting at routine liquidity but raising investor curiosity about future confidence.

iRadimed insider selling signals a quiet shift: Allen Monty K sells 1,000 shares post‑Q4 earnings, hinting at portfolio realignment amid strong growth and dividend hikes.